Provided by Tiger Trade Technology Pte. Ltd.

Bolt Biotherapeutics, Inc.

5.45
+0.00010.00%
Post-market: 5.30-0.1500-2.75%16:10 EST
Volume:29.45K
Turnover:161.61K
Market Cap:10.46M
PE:-0.24
High:5.64
Open:5.50
Low:5.40
Close:5.45
52wk High:12.60
52wk Low:4.41
Shares:1.92M
Float Shares:1.44M
Volume Ratio:0.88
T/O Rate:2.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-22.2638
EPS(LYR):-33.0600
ROE:-81.97%
ROA:-32.04%
PB:0.33
PE(LYR):-0.16

Loading ...

Jeep Parent Stellantis And Bolt Team Up To Launch Robotaxis Across Europe

Benzinga_recent_news
·
Dec 09

Bolt Metals Secures $430,000 in First Tranche of LIFE Offering

TIPRANKS
·
Nov 20

Bolt Biotherapeutics posts Q3 revenue of $2.2 million and R&D expenses of $6.5 million

Reuters
·
Nov 13

Bolt Biotherapeutics Inc expected to post a loss of $5.79 a share - Earnings Preview

Reuters
·
Nov 07

Bolt Biotherapeutics’ Pioneering Study on BDC-4182: A New Hope for Cancer Treatment

TIPRANKS
·
Oct 28

Senior VP Sarah Nemec Acquires Common Shares of Bolt Biotherapeutics Inc

Reuters
·
Oct 25

William P. Quinn, President, CEO and CFO, acquires common shares of Bolt Biotherapeutics Inc

Reuters
·
Oct 25

Bolt Metals Corrects Private Placement Amount in Recent Announcement

TIPRANKS
·
Oct 24

Bolt Metals Advances Northwind Gold Project Amidst Soaring Gold Prices

TIPRANKS
·
Oct 24

Bolt Biotherapeutics Coverage Assumed by HC Wainwright & Co. at Buy

Dow Jones
·
Oct 20

Bolt Biotherapeutics Inc : H.c. Wainwright Assumes Coverage With Buy Rating; Target Price $7

THOMSON REUTERS
·
Oct 20

Bolt Metals Announces Share Consolidation and Strategic Portfolio Update

TIPRANKS
·
Oct 16

Bolt Metals Closes $600,000 Private Placement to Bolster Working Capital

TIPRANKS
·
Oct 11

Bolt Biotherapeutics Announces Major Restructuring Plan

TIPRANKS
·
Oct 03

Bolt Biotherapeutics Announces Protocol Update and New Timeline for BDC-4182 Phase 1 Trial, Extends Cash Runway Into 2027

Reuters
·
Oct 03

Sector Update: Health Care Stocks Retreat Late Afternoon

MT Newswires Live
·
Oct 03

BUZZ-U.S. STOCKS ON THE MOVE-AMD, Occidental Petroleum, Bolt Biotherapeutics

Reuters
·
Oct 02

BUZZ-Bolt Biotherapeutics dips after cancer therapy trial delay

Reuters
·
Oct 02

Bolt Biotherapeutics to reduce workforce by 50%, gives update on BDC-4182 study

TIPRANKS
·
Oct 02

Bolt Biotherapeutics Announces 50% Workforce Reduction to Extend Cash Runway Into 2027 Amid Clinical Program Update

Reuters
·
Oct 02